Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
The Journal of Pathology|September 13, 2018
Tumor suppressive function of E2F-1 on PTEN-induced serrated colorectal carcinogenesisMaria A Dosil, Raúl Navaridas, Cristina Mirantes, et al.
Melanoma Research|March 29, 2006
Antiproliferative effect of STI571 on cultured human cutaneous melanoma-derived cell linesMaritza E Mayorga, Daniel Sanchis, Ana M Perez de Santos, et al.
Molecular Oncology|November 21, 2022
Oxidative stress-induced FAK activation contributes to uterine serous carcinoma aggressivenessIsabel C Lopez-Mejia, Jordi Pijuan, Raúl Navaridas, et al.
The Journal of Clinical Endocrinology and Metabolism|March 5, 2009
Genetics of pheochromocytoma and paraganglioma in Spanish patientsAlberto Cascón, Guillermo Pita, Nelly Burnichon, et al.
Trials|January 21, 2021
Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trialElena Diago-Sempere, José Luis Bueno, Aránzazu Sancho-López, et al.
International Journal of Cancer|January 19, 2020
Detection of somatic mutations in peritoneal lavages and plasma of endometrial cancer patients: A proof-of-concept studyClara Mayo-de-Las-Casas, Ana Velasco, Douglas Sanchez, et al.
Anaesthesia, Critical Care & Pain Medicine|September 27, 2025
Universal videolaryngoscopy for double-lumen tube tracheal intubation: Subanalysis of the VIDEOLAR-SURGERY trialManuel Taboada, Jorge Fernández, Cristina Francisco, et al.
Cancer Medicine|September 22, 2025
One-Step Nucleic Acid Amplification Analysis of Sentinel Lymphatic Nodes in Endometrial Cancer Patients (EU-OSNA): A European Multicenter Diagnostic Accuracy StudyJan Kostun, Krzysztof Nowosielski, Marcin A Jedryka, et al.
Vox Sanguinis|February 3, 2023
Pathogen reduction with methylene blue does not have an impact on the clinical effectiveness of COVID-19 convalescent plasmaIrene Romera Martínez, José Luis Bueno Cabrera, José María Domingo-Morera, et al.
Vox Sanguinis|November 21, 2023
Factors related to the development of high antibody titres against SARS-CoV-2 in convalescent plasma donors from the ConPlas-19 trialIrene Romera Martínez, Cristina Avendaño-Solá, Carolina Villegas Da Ros, et al.
Pageof 8